Douglas P. Malinowski, Ph.D., is the Vice President of Clinical Affairs at PreciseDx and brings over 40 years of experience and expertise in technology development and clinical diagnostics. Prior to joining PreciseDx, he held various leadership positions at BD Diagnostics, BD Gene, TriPath Oncology, and the BD Corporate Research Center. Doug graduated Magna Cum Laude from Notre Dame University with a degree in Chemistry. He received a Doctor of Philosophy (Ph.D.) degree in Biochemistry and Enzymology from Duke University and a Postdoctoral Fellowship in Biochemistry and Molecular Biology from the University of Washington. Doug’s career has focused on the identification of new opportunities in clinical diagnostics related to molecular oncology and microbial genomics. These specialties have led to multiple technical solutions, novel diagnostic products, and strategic innovations which addressed unmet clinical needs in cancer detection, disease characterization, and patient management.
Sign up to view 0 direct reports
Get started